UNSPSC 51342002: Disoxaril

This classification denotes an antiviral agent with the molecular formula C20H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FX8Q9PI4VP, chemically known as 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole but generally known as disoxaril, which bears US NIH Compound Identifier 55717. European Medicines Agency schedules Disoxaril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06322MIG.

UNSPSC 51342002 Disoxaril is a Commodity code that does not align with the state and local procurement activity recently posted under this designation. The source includes four recent opportunities tagged with this code, but only one directly involves the pharmaceutical product named in the code; the others cover naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle, and a Texas Health and Human Services Commission request for information on direct-to-manufacturer prescription programs. State and local governments buying under this code are purchasing emergency response pharmaceuticals, general medical supplies, and pharmacy benefit program products rather than disoxaril specifically. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (Tampa), state health and human services commissions (Texas), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), with participation extending to multiple states through MMCAP's multi-jurisdictional membership.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with the most concrete opportunities being Seminole County's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023), the City of Tampa's ITB 26P00145 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00 (due March 13, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026. The code shows little relevant recent activity for disoxaril as a discrete product line; the mismatch between the code's nominal scope and the actual purchasing pattern suggests this code may be incorrectly applied in the source data.